Xuping Yang

Luzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Artificial intelligence and extracellular vesicles in oncology: towards tumor diagnosis, prediction, and therapy.

Artificial intelligence and extracellular vesicles in oncology: towards tumor diagnosis, prediction, and therapy.

Journal: Drug delivery
Published: August 13, 2026

Research progress of depression and pain comorbidity: Animal model, mechanism, treatment strategy.

Research progress of depression and pain comorbidity: Animal model, mechanism, treatment strategy.

Journal: Brain research bulletin
Published: March 05, 2026

Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism.

Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism.

Journal: Oncology reports
Published: February 12, 2026

Pleiotropic mechanisms and translational trajectory of SGLT2 inhibitors in sepsis-induced cardiomyopathy: Navigating the evidence hierarchy.

Pleiotropic mechanisms and translational trajectory of SGLT2 inhibitors in sepsis-induced cardiomyopathy: Navigating the evidence hierarchy.

Journal: European journal of pharmacology
Published: January 25, 2026

Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies.

Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies.

Journal: Frontiers in endocrinology
Published: November 17, 2025

The Potential Role of SGLT2 Inhibitors in the Treatment of Depression: Mechanisms and Clinical Prospects.

The Potential Role of SGLT2 Inhibitors in the Treatment of Depression: Mechanisms and Clinical Prospects.

Journal: Drug design, development and therapy
Published: September 16, 2025

Adipose tissue-targeted drug delivery for treating obesity: current opportunities and challenges.

Adipose tissue-targeted drug delivery for treating obesity: current opportunities and challenges.

Journal: Drug delivery
Published: August 22, 2025

SGLT2 Inhibitors in Combination Therapies for Tumors: A Novel Approach to Synergistic Treatment Strategies.

SGLT2 Inhibitors in Combination Therapies for Tumors: A Novel Approach to Synergistic Treatment Strategies.

Journal: Drug design, development and therapy
Published: July 25, 2025

Canagliflozin regulates adipocyte lipolysis in vitro via a SGLT2 independent signaling pathway.

Canagliflozin regulates adipocyte lipolysis in vitro via a SGLT2 independent signaling pathway.

Journal: International journal of obesity (2005)
Published: March 25, 2025

SGLT2 inhibitors in autoimmune diseases: emerging therapeutic potential and clinical challenges.

SGLT2 inhibitors in autoimmune diseases: emerging therapeutic potential and clinical challenges.

Journal: Frontiers in immunology
Published: March 07, 2025

DIA-based quantitative proteomics explores the mechanism of amelioration of APAP-induced liver injury by anoectochilus roxburghii (Wall.) Lindl.

DIA-based quantitative proteomics explores the mechanism of amelioration of APAP-induced liver injury by anoectochilus roxburghii (Wall.) Lindl.

Journal: Frontiers in pharmacology
Published: October 30, 2024

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model.

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model.

Journal: Frontiers in pharmacology
Published: October 03, 2024
Showing 1-12 of 26

Last Updated: 09/26/2026